D Lucas Kerr
8PUBLICATIONS
133CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.Collin M Blakely, Anatoly Urisman, Matthew A Gubens
|Jun 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.Sebastijan Hobor, Maise Al Bakir, Crispin T Hiley
|May 03, 2024
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.Franziska Haderk, Yu-Ting Chou, Lauren Cech
|Apr 18, 2024
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors.Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee
|Dec 04, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.Deborah R Caswell, Philippe Gui, Manasi K Mayekar
|Jul 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee
Pageof 2
Frequent Collaborators
7 joint publications
Trever G Bivona
6 joint publications
Collin M Blakely
5 joint publications
Wei Wu
2 joint publications
James R M Black
2 joint publications
Whitney Tamaki
2 joint publications
Eytan Ruppin
2 joint publications
Shigeki Nanjo
2 joint publications
Maise Al Bakir
2 joint publications
Mihaela Angelova
2 joint publications
Sanju Sinha
